Votrient 200mg

Votrient 200mg tablet contains pazopanib as its active ingredient. This antineoplastic medication is classified as a tyrosine kinase inhibitor. It is prescribed for adults to manage advanced kidney cancer or cancer that has metastasized to other organs. Additionally, it is indicated for certain types of soft-tissue sarcoma, which is a cancer that impacts the body’s supportive tissues. The mechanism of this drug involves inhibiting the activity of proteins that contribute to the growth and dissemination of cancer cells.

Do not use Votrient 200mg tablet if you have an allergy to pazopanib or any other components of this medication. Prior to starting treatment, it is essential to inform your healthcare provider if you have any issues related to your kidneys, heart, lungs, or liver, as well as any bleeding disorders, gastrointestinal problems, or thyroid conditions. This tablet has the potential to elevate your blood pressure, so regular monitoring is crucial during the course of treatment. Patients with kidney disease do not require any dose modifications.

Your physician will instruct you to discontinue Votrient 200mg tablet at least 7 days prior to any surgical or dental procedures you may have, as it could interfere with the healing process. This medication is not advised for individuals under the age of 18. It may also lead to infertility, so it is important to discuss this with your doctor before starting the treatment. Common side effects include diarrhea, high blood pressure, changes in hair color, nausea, and vomiting.